Diabetic Ketoacidosis and Acute Pancreatitis: Serious Adverse Effects of Everolimus
The Food and Drug Administration has approved everolimus for treating a variety of cancers. Everolimus inhibits signaling in the PI3K/AKT/MTOR pathway, which is critical for cell growth and angiogenesis. It…